Pascal BEAUCHESNE
5Patents
1h-index
30Co-inventors
47Inventor score
Filing activity: Apr 23, 2015 → Dec 16, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11400115B2 | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | Emerging Cross-Sectional Technologies | 11 | Active |
| US12208137B2 | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US12258580B2 | Process for generating therapeutic compositions of engineered cells | Chemistry; Metallurgy | 0 | Active |
| US12296010B2 | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | Emerging Cross-Sectional Technologies | 0 | Active |
| US12163952B2 | Determining toxicity risk in CAR T-cell therapy | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.